Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Dietlein

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
JCO Precision Oncology|September 8, 2022
Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid CancerJulia Schiantarelli, Theodora Pappa, Jake Conway, et al.
Nature Cancer|February 5, 2022
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncologyBrendan Reardon, Nathanael D Moore, Nicholas S Moore, et al.
Cancer Research|May 20, 2018
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung CancerLydia Meder, Philipp Schuldt, Martin Thelen, et al.
JCI Insight|May 22, 2024
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasisLydia Meder, Charlotte Isabelle Orschel, Christoph Julius Otto, et al.
Cancer Research|June 8, 2021
Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell SurvivalRiaz Gillani, Bo Kyung A Seong, Jett Crowdis, et al.
JCO Precision Oncology|December 14, 2019
Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non-Small-Cell Lung CancerNatalie I Vokes, David Liu, Biagio Ricciuti, et al.
Cell Reports|April 30, 2020
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLCCaroline Volz, Sara Breid, Carolin Selenz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancerMartin L Sos, Felix Dietlein, Martin Peifer, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
JCO Precision Oncology|September 8, 2022
Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid CancerJulia Schiantarelli, Theodora Pappa, Jake Conway, et al.
Nature Cancer|February 5, 2022
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncologyBrendan Reardon, Nathanael D Moore, Nicholas S Moore, et al.
Cancer Research|May 20, 2018
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung CancerLydia Meder, Philipp Schuldt, Martin Thelen, et al.
JCI Insight|May 22, 2024
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasisLydia Meder, Charlotte Isabelle Orschel, Christoph Julius Otto, et al.
Cancer Research|June 8, 2021
Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell SurvivalRiaz Gillani, Bo Kyung A Seong, Jett Crowdis, et al.
JCO Precision Oncology|December 14, 2019
Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non-Small-Cell Lung CancerNatalie I Vokes, David Liu, Biagio Ricciuti, et al.
Cell Reports|April 30, 2020
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLCCaroline Volz, Sara Breid, Carolin Selenz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancerMartin L Sos, Felix Dietlein, Martin Peifer, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.
Pageof 5